Audiological Assessment of Recovered Covid 19 Subjects.
1 other identifier
observational
70
0 countries
N/A
Brief Summary
To assess the audiological profile in recovered covid 19 subjects in comparison with control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2021
CompletedFirst Posted
Study publicly available on registry
September 22, 2021
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedSeptember 24, 2021
September 1, 2021
1 year
September 17, 2021
September 21, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Audiological assessment of recovered covid 19 subjects
To evaluate the audiological profile of recoveredcovid 19 subjects in comparison with control group
base line
Interventions
TO assess audiological profile in recovered covid19 subjects
Eligibility Criteria
Male or female subjects have recovered from covid 19 ..their age from 18\_50
You may qualify if:
- Age 18\_50
You may not qualify if:
- History of previous ear symptoms, tympanic membrane perforations,ear trauma or ear surgeries
- Evidence of systemic illness as Diabetes mellitus, Renal disease, patients received ototoxic drugs.
- Evidence of neurologicl or psychiatric disease.
- covid 19 Patients not maintaining saturation and requiring O2 support and intensive care unit patient.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Fancello V, Hatzopoulos S, Corazzi V, Bianchini C, Skarzynska MB, Pelucchi S, Skarzynski PH, Ciorba A. SARS-CoV-2 (COVID-19) and audio-vestibular disorders. Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211027373. doi: 10.1177/20587384211027373.
PMID: 34142589BACKGROUNDAlmufarrij I, Munro KJ. One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms. Int J Audiol. 2021 Dec;60(12):935-945. doi: 10.1080/14992027.2021.1896793. Epub 2021 Mar 22.
PMID: 33750252RESULTDharmarajan S, Bharathi MB, Sivapuram K, Prakash BG, Madhan S, Madhu A, Devi GN, Aliya SA, Ramya SB. Hearing Loss-a Camouflaged Manifestation of COVID 19 Infection. Indian J Otolaryngol Head Neck Surg. 2021 Dec;73(4):494-498. doi: 10.1007/s12070-021-02581-1. Epub 2021 May 10.
PMID: 33996529RESULTDusan M, Milan S, Nikola D. COVID-19 caused hearing loss. Eur Arch Otorhinolaryngol. 2022 May;279(5):2363-2372. doi: 10.1007/s00405-021-06951-x. Epub 2021 Jul 8.
PMID: 34235578RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident doctor
Study Record Dates
First Submitted
September 17, 2021
First Posted
September 22, 2021
Study Start
October 1, 2021
Primary Completion
October 1, 2022
Study Completion
April 1, 2023
Last Updated
September 24, 2021
Record last verified: 2021-09